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What is already known on this subject? 
The aetiology of sarcopenia is not well understood, but it is highly prevalent in older adults. 
Previous investigations using cross-sectional and retrospective design suggested that physical 
activity may prevent sarcopenia. 
The aging processes differ between men and women. 
 
What this study adds? 
Women are at 20% higher risk of developing incident sarcopenia than men. 
Men benefit from physical activity of moderate and vigorous intensities in preventing incident 
sarcopenia, but this benefit requires vigorous intensity in women, which might be due to differed 
hormone production.  
Social factors, wealth, appeared to be more strongly preventive of sarcopenia in men, suggesting 
gender as a social and psychological factor that is not merely biological. 
  
ABSTRACT  
Background: The aetiology of age-related sarcopenia is not known.  
Objectives: To investigate if risk of developing sarcopenia differs by gender; and to identify gender-
specific risk factors of incident sarcopenia, in a large population-based cohort of older English 
adults. 
Methods: The sample (n=3,404; age 63.4 (SD 7.7) yrs; 54.1% female) comprised older community 
dwelling adults recruited from the English Longitudinal Study of Ageing. Sarcopenia was defined as 
hand grip <26kg in men, <16kg in women. Handgrip strength was assessed at baseline (2004/5) 
and repeated at follow up (2012/13). Analysed risk factors included baseline anthropometric 
measures, smoking, vigorous and moderate physical activity, depressive symptoms, chronic 
illnesses, and wealth. After excluding participants with sarcopenia at baseline, multivariate logistic 
regressions were used to explore baseline risk factors for incident sarcopenia. 
Results: During 8 years follow up, 208 and 287 cases of sarcopenia were identified in men 
(n=1564) and women (n=1840), respectively. Women were at 20% (age adjusted OR=1.20, 95% CI, 
0.98, 1.47) higher risk of developing sarcopenia than men. The inverse association between 
physical activity and sarcopenia risk was observed at moderate (OR=0.44, 95% CI, 0.27, 0.67) and 
vigorous (0.53, 95% CI, 0.31, 0.82) intensities in men and only vigorous (OR=0.44, 95% CI, 0.28, 
0.68) intensity in women. Social factors, such as wealth, and chronic health conditions appeared to 
be more strongly associated with sarcopenia in men.  
Conclusion: Women are at higher risk of developing incident sarcopenia than men and this is likely 
explained by a range of gender-specific risk factors.  
 
 
 
  
INTRODUCTION 
Age-related sarcopenia is one of the most deleterious effects of aging. Presenting with loss of 
muscle mass, strength and function, sarcopenia has a major impact on quality of life in the elderly, 
development of physical disability, and mortality [1, 2]. The aetiology of sarcopenia is not well 
understood, but it is highly prevalent in older adults; up to 20% of the older population worldwide are 
thought to be living with sarcopenia, even among the apparently healthy [3]. Coupled with the 
rapidly growing ageing population worldwide, sarcopenia is projected to result in excessive health 
care and economic burden in the near future [4].  
Several mechanisms have been proposed to explain the development of sarcopenia, centering on 
protein synthesis, proteolysis, neuromuscular integrity and muscle fat content [5]. Recent 
epidemiological studies support the role of physical activity as a protective factor against sarcopenia 
development, yet the basis of current evidence is cross-sectional or retrospective investigations [6]. 
Moreover, only few investigations [7] have considered gender-specific risk factors in sarcopenia, 
despite the clear difference in immune response homeostasis between men and women and 
subsequent disease risks in their aging process [8].  
To fill the knowledge gap, primary aims of the present study were to investigate 1) if risk of 
prospectively developing sarcopenia differs by gender; and to identify 2) gender-specific risk factors 
of incident sarcopenia, in a large population based cohort of older English adults. 
METHODS 
The English Longitudinal Study of Ageing (ELSA) is a cohort study of older, community dwelling 
adults previously described [9]. Data on grip strength was first collected at wave 2 (2004/5), and 
was thus used as the baseline for the present analyses. Handgrip assessments were repeated at 
wave 6 (2012/13) in survivors.  Participants gave full informed consent to participate in the study. 
Ethical approval was obtained from the London Multi-center Research Ethics Committee, compliant 
with the Declaration of Helsinki. Anthropometric data (waist, hip), and grip strength were collected 
by trained nurses. Participants were excluded from hand grip tests if they had swelling or 
inflammation, severe pain, or a recent injury or surgery to the hand in the preceding 6 months. 
Handgrip strength (kg) of the dominant hand was assessed using the Smedley hand-held 
dynamometer (Stoelting Co, IL, USA), using the average of three measurements from the dominant 
hand. Participants held the device at a right angle to their body and exerted maximum force for a 
couple of seconds when instructed. Waist circumference was recorded twice midway between the 
iliac crest and lower rib and hip circumference around the widest portion of the buttocks using 
measuring tape. Central obesity was defined using waist to hip ratio (WHR) World Health 
Organization criteria (WHR≥0.85 in women and WHR≥0.90 in men) [10]. Trained interviewers asked 
questions on cigarette smoking (current, ex-smoker or non-smoker), alcohol consumption (1-
4/week, rarely, not in past 12 months), frequency of vigorous, moderate- and low-intensity physical 
activity (> once a week, once a week, 1 – 3 times a month, and hardly ever/never),  depressive 
symptoms (using a score >3 on the 8-item Centre of Epidemiological Studies Depression scale), 
activity limiting illness (no, yes)[11] and diabetes (no, yes). Wealth was grouped into quintiles, 
comprising of the total value of the participant’s home (excluding mortgage), and other financial 
assets. Sarcopenia was defined as hand grip <26kg men, <16kg women [12]. After excluding 
participants with sarcopenia at baseline we used multivariate logistic regression to explore 
longitudinal associations between psychosocial and clinical risk factors with incident sarcopenia. All 
analyses were conducted using SPSS version 22 (SPSS, Chicago, IL).  
RESULTS 
At baseline 7,666 participants provided data on handgrip strength. After removing participants with 
sarcopenia at baseline (n=1,265), those that died through follow up (n=796), and those with missing 
covariates and follow-up data (n= 2,201) the analytic sample for multivariate logistic regression 
analyses comprised 3,404 participants (mean age 63.4 (SD 7.7) yrs; 54.1% female). During 8 years 
follow up, 208 and 287 cases of sarcopenia were identified in men (n=1564) and women (n=1840), 
respectively.  
We observed an elevated risk of developing sarcopenia among women (OR=1.20, 95% CI, 0.98, 
1.47) comparing to men in the age-adjusted model. In multivariate adjusted gender-specific models, 
age and physical activity level were significantly associated with incident sarcopenia in both 
genders. Such that older age were associated with higher risk of sarcopenia (men, OR=1.16, 95% 
CI, 1.14, 1.19; women, OR=1.12, 95% CI, 1.10, 1.14); physical activity of moderate (OR=0.44, 95% 
CI, 0.27, 0.67) and vigorous (0.53, 95% CI, 0.31, 0.82) intensities were protective of sarcopenia in 
men, but an association was only exhibited at vigorous intensity (OR=0.44, 95% CI, 0.28, 0.68) in 
women.   
Activity limiting illness was associated with higher risk of developing sarcopenia in men (OR=1.49, 
95% CI, 1.03, 2.18) but not in women (OR=1.29, 95% CI, 0.94, 1.77). Similarly, baseline diabetes 
diagnosis was associated with higher likelihood of incident sarcopenia in men (OR=2.43, 95% CI, 
1.50, 3.95) but not in women (OR=1.49, 95% CI, 0.83, 2.68). Higher wealth status was associated 
with lower risk of sarcopenia in a dose-response manner, particularly in men. We observed no 
statistically significant associations in relation to incident sarcopenia with other risk factors, including 
smoking, alcohol consumption, depressive symptoms, and central obesity (Table 1). 
DISCUSSION 
In the present population based sample of older English adults, women were at 20% higher risk of 
developing sarcopenia than men over 8 years follow-up. There appear to be a range of gender-
specific risk factors for incident sarcopenia, notably, the benefit of physical activity at moderate and 
vigorous intensities in men and only vigorous intensity in women. In addition, social factors, such as 
wealth, appeared to be more strongly preventive of sarcopenia in men. Chronic conditions such as 
activity limiting illness and diabetes may put men at higher risk of incident sarcopenia, likely owing 
to low levels of physical activity associated with such conditions.  
Our findings support previous research on the role of physical activity in preventing sarcopenia [6]. 
The present study is one of the first to extend the beneficial influence of physical activity with 
longitudinal data. The greater benefit of physical activity engagement in men than in women has 
been previously reported in a cross-sectional study [13] that found associations of physical activity 
with muscle volume and functional parameters in men, but null association in women. In that study, 
physical activity was defined using average MET (metabolic equivalent) value. This approach does 
not consider the intensity of physical activity, unlike the present approach that identified the benefit 
of vigorous physical activity in women. The stronger association of physical activity with incident 
sarcopenia in men than in women could also explain the higher risk of incident sarcopenia in men 
with activity limiting illness and diabetes but not in women, since such conditions often restrict 
individuals from being physically active. 
There is a growing interest in gender-specific differences in the development of sarcopenia, notably 
the role of androgens given that mechanistic studies found testosterone levels to be associated with 
sarcopenia [14]. Moreover, recent in vivo and in vitro studies suggested that testosterone may 
enhance the benefit of low-intensity physical training on skeletal muscle mitochondrial function in 
elderly male mice [15]. Owing to different male and female homeostasis, it is likely that male muscle 
anabolic activity is more prone to external stimuli (such as physical activity) than women [16]. 
Another protective factor of incident sarcopenia identified in men was a higher level of wealth. This 
finding is important because ageing is a complex process and not merely biological. Wealth is a key 
indicator of socioeconomic status in this population. We speculate that level of wealth may signify 
the quality of nutrition, yet it is unclear why the impact of wealth on incident sarcopenia differs 
between men and women. Future research should consider the inclusion of gender as a social and 
psychological factor to identify how social economics and contextual factors may later influence the 
risk of sarcopenia. 
Strengths of the present study include the large population based sample of older English adults 
and the longitudinal design. However, the data must be interpreted considering the following 
limitations. We used a single measure of muscle strength to assess sarcopenia. Although a unified 
geriatric assessment tool is yet to be widely implemented to diagnose sarcopenia, handgrip strength 
has been commonly used to measure muscle strength, a critical component of sarcopenia [5]. It has 
been widely used in research and clinical settings [17, 18] and shown to be an independent 
predictor of all-cause mortality [19, 20]. Other limitations include limited adjustment for sub-clinical 
disease process and severity of disease. Further, participants retained in our analyses were 
generally healthier than the overall sample, thus bias may rise with likely lower incidental 
sarcopenia in the analysed sample.  
In conclusion, the present longitudinal analyses suggest that women are at 20% higher risk of 
developing incident sarcopenia than men that may be explained by a range of gender-specific risk 
factors.  
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Table 1. Risk factors for incident sarcopenia† over 8 years follow up in men and women from 
ELSA 
 
Baseline risk factor Men 
OR (95% CI) 
[cases=208; n=1564] 
Women 
OR (95 % CI) 
[cases=287; n=1840] 
Age  
 
1.16 (1.14, 1.19) 1.12 (1.10, 1.14) 
Physical activity  
Inactive 
Moderate 
Vigorous  
 
1.0 (Ref) 
0.44 (0.27, 0.67) 
0.53 (0.31, 0.82) 
 
1.0 (Ref) 
0.85 (0.55, 1.22) 
0.44 (0.28, 0.68) 
Smoking 
None 
Current  
 
1.0 (Ref) 
1.29 (0.75, 2.19) 
 
1.0 (Ref) 
0.80 (0.53, 1.21) 
Alcohol 
Daily 
1 – 4 /wk 
Rarely 
Not in past 12 months 
 
1.0 (Ref) 
1.17 (0.77, 1.76) 
1.15 (0.75, 1.92) 
1.02 (0.57, 2.22) 
 
1.0 (Ref) 
1.13 (0.74, 1.73) 
1.13 (0.74, 1.73) 
1.30 (0.77, 2.22) 
Wealth 
1 (lowest) 
2 
3 
4 
5 (highest) 
 
1.0 (Ref) 
0.75 (0.43, 1.38) 
0.63 (0.35, 1.14) 
0.52 (0.28, 0.93) 
0.44 (0.24, 0.81) 
 
1.0 (Ref) 
1.26 (0.79, 2.01) 
0.60 (0.37, 0.95) 
0.77 (0.47, 1.23) 
0.63 (0.38, 1.02) 
Depressive symptoms 
CESD < 4 
CESD ≥ 4 
 
1.0 (Ref) 
0.82 (0.45, 1.51) 
 
1.0 (Ref) 
1.19 (0.81, 1.75) 
Activity limiting illness 
No 
Yes  
 
1.0 (Ref) 
1.49 (1.03, 2.18) 
 
1.0 (Ref) 
1.29 (0.94, 1.77) 
Central obesity 
No 
Yes  
 
1.0 (Ref) 
0.84 (0.60, 1.18) 
 
1.0 (Ref) 
1.12 (0.84, 1.49) 
Diabetes 
No 
Yes  
 
1.0 (Ref) 
2.43 (1.50, 3.95) 
 
1.0 (Ref) 
1.49 (0.83, 2.68) 
†Cases of sarcopenia at follow up defined as hand grip <26kg men, <16kg women; 
Participants with sarcopenia at baseline were removed. 
Odds ratios are mutually adjusted for all presented variables. 
 
 
